Glaukos CORP Form 4 insider transactions

NYSE
Thomas Burns, Chairman & CEO of Glaukos Corp, reports acquisition of shares and options due to the achievement of pre-determined operational targets, as determined by the Compensation, Nominating and Governance Committee.
NYSE
Director Kliman Gilbert H reports exercising stock options and selling shares of Glaukos Corp on September 9, 2024.
NYSE
Joseph Gilliam, President & COO of Glaukos Corp, exercised stock options and sold shares on August 21, 2024, according to a recent SEC filing.
NYSE
Director Marc Stapley exercised stock options and sold Glaukos Corp shares on August 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director Aimee S. Weisner exercised stock options and sold 25,000 shares of Glaukos Corp stock on August 8, 2024.
NYSE
Thomas Burns, Chairman and CEO of Glaukos Corp, reports the disposal of 1,057 shares to cover tax obligations upon vesting of restricted stock units.
NYSE
Chief Development Officer of Glaukos Corp, Tomas Navratil, reports disposition of shares to cover tax obligations upon vesting of restricted stock units.
NYSE
Joseph E. Gilliam, President & COO of Glaukos Corporation, executed a stock option exercise and subsequent sale of shares on July 5, 2024, according to a Form 4 filing with the SEC.
NYSE
Thomas Burns, CEO of Glaukos Corporation, reported the disposal of shares to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Tomas Navratil, Chief Development Officer at Glaukos Corporation, reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Joseph Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock on June 3, 2024, according to a recent SEC Form 4 filing.
NYSE
Director Kliman Gilbert H reports exercising stock options and selling shares of Glaukos Corp, along with receiving a grant of restricted stock units.
NYSE
Director Aimee Weisner reported the acquisition of restricted stock units and stock options in Glaukos Corporation.
NYSE
Director Denice Torres reported the acquisition of restricted stock units and stock options in Glaukos Corporation on May 30, 2024.
NYSE
Director Leana Wen reported the acquisition of restricted stock units and stock options in Glaukos Corporation on May 30, 2024.
NYSE
Director Mark Foley reported the acquisition of restricted stock units and stock options in Glaukos Corporation on May 30, 2024.
NYSE
Director Marc Stapley of Glaukos Corp reports acquisition of restricted stock units and stock options.
NYSE
Director David F. Hoffmeister reports the acquisition of restricted stock units and stock options in Glaukos Corporation.
NYSE
Director Marc Stapley exercised stock options and sold shares of Glaukos Corp (GKOS) on May 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock on May 10, 2024, according to a Form 4 filing with the SEC.
NYSE
Alex R. Thurman, SVP & CFO of Glaukos Corporation, sold a portion of his holdings in common stock under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares on May 6, 2024, according to a Form 4 filing with the SEC.
NYSE
Alex R. Thurman, SVP & CFO of Glaukos Corporation, sold 90 shares of common stock on May 6, 2024, at a price of $110.26 per share.
NYSE
Alex R. Thurman, SVP & CFO of Glaukos Corporation, sold a portion of his common stock holdings on May 2, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock on May 2, 2024, according to a Form 4 filing with the SEC.
NYSE
Director David F. Hoffmeister exercised stock options and reported changes in beneficial ownership of Glaukos Corp shares.
NYSE
Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock on April 8, 2024, according to a Form 4 filing with the SEC.
NYSE
Alex R. Thurman, SVP & CFO of Glaukos Corporation, executed multiple sales of common stock between April 5th and April 8th, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
NYSE
Joseph E. Gilliam, President & COO of Glaukos Corporation, reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.